Application no. and date | 13763497.8 (espacenet) (Federated) (European Patent Register), 20130315 | Patent/reg. no. and date | DK/EP 2828332, 20170510 | Publication date | 20150128 | Priority no. and date | US 201261613885 P, 20120321 | EP pub. no. and date |
EP 2828332 20150128 | Effective date | | Applicant/owner | enGene, Inc., 2386 East Mall Suite 111
Vancouver, British Columbia V6T 1Z3, CA | Applicant ref. no. | V1707-054-DK | Inventor | HSU, Eric, 5870 Fremlin Street
Vancouver, British Columbia V5Z 3W7, CA, GAO, Jun, 607 Langside Avenue
Coquitlam, British Columbia V3J 2Y7, CA, CHEUNG, Anthony, 3-3960 St Hubert
Montreal, QC, CA | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/7088 (2006.01) , A61K 9/14 (2006.01) , C07H 21/00 (2006.01) , C08L 5/08 (2006.01) , C12N 15/113 (2010.01) , C12N 15/87 (2006.01) | Title | DOBBELTDERIVATISEREDE CHITOSANNANOPARTIKLER OG FREMGANGSMÅDER TIL FREMSTILLING OG ANVENDELSE HERAF TIL GENOVERFØRSEL IN VIVO | Int. application no. | CA2013050218 | Int. publication no. | WO2013138930 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|